KIT DE DIAGNÓSTICO IN VITRO PARA ÁCIDO NUCLEICO DE CORONAVIRUS DEL SARS-COV- 2
Mexico·Clase II·III. Agentes de
diagnóstico·ABALAT, S.A. DE C.V.·Registered March 22, 2024- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- GENEFINDER COVID-19 PLUS REALAMP KIT
- Trade Name (English)
- GENEFINDER COVID-19 PLUS REALAMP KIT
- Analysis ID
- 0774R2024 SSA
- Registration Date
- March 22, 2024
- Name (Spanish)
- ABALAT, S.A. DE C.V.
- Name (English)
- ABALAT, S.A. DE C.V.
Access comprehensive regulatory information for KIT DE DIAGNÓSTICO IN VITRO PARA ÁCIDO NUCLEICO DE CORONAVIRUS DEL SARS-COV- 2 (KIT DE DIAGNÓSTICO IN VITRO PARA ÁCIDO NUCLEICO DE CORONAVIRUS DEL SARS-COV- 2) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 0774R2024 SSA and manufactured by ABALAT, S.A. DE C.V.. The device was registered on March 22, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.